Approval · Notice of Compliance 4995 · 1995
CHOLOXIN: Notice of Compliance 4995
Issued June 13, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4995
- Date
- June 13, 1995
- Company
- Knoll Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Hypolipidemic thyroactive agent
Products in this notice
Medicinal ingredients
- DEXTROTHYROXINE SODIUM 2 MG per TAB
- DEXTROTHYROXINE SODIUM 4 MG per TAB